Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06748209

Establishing Mobile Transcranial Magnetic Stimulation

In this pilot study, investigators propose to design and create a portable TMS unit, in a van, and then test out delivering TMS in three different locations in South Carolina, all affiliated with MUSC and within 2-hours driving from Charleston, SC. This study would test out this new delivery mode, and provide valuable feasibility, safety, and efficacy lessons for later refinement and potential widespread adoption of mobile TMS as a treatment option, both in our state and across the US.

Recruiting

Interested in participating?

Request Info

Key information

Age range

22 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Medical Univerity of South Carolina

Charleston, South Carolina, 29425, United States

Location status: Recruiting

Location contact

Mark S. George, MD

CONTACT

[email protected]

8438765142

About this study

In this pilot study, investigators propose to design and create a portable TMS unit, in a van, and then test out delivering TMS in three different locations in South Carolina, all within 90 minutes driving from Charleston, SC. This study would test out this new delivery mode, and provide valuable lessons for later refinement and potential widespread adoption of mobile TMS as a treatment option. This would open up access to TMS for millions of patients with treatment resistant depression who cannot be treated in the current model. After this pilot feasibility and efficacy study, future research would use mobile TMS units for siting at residential care facilities, or remote hospitals and clinics.

Investigators aim to determine whether it is possible to assemble and build a functioning mobile TMS unit. After assembling the van, investigators will then recruit up to 30 treatment-resistant depression patients who live near one of three satellite MUSC clinics. These clinics are all within a 2 hour drive from the MUSC Charleston campus. Investigators will treat these patients, open label, with FDA approved accelerated TMS (6 sessions each day, over 2 hours, for 5 days, spread over one or two weeks). Investigators will measure TMS effectiveness using standard depression rating scales. Importantly, investigators will also collect the costs of performing the TMS which will inform whether MUSC or other health delivery systems might adopt this TMS method.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult (22-80 years old)
  • Have treatment-resistant depression as defined by the e-Mini, and the antidepressant treatment history form (ATHF short).
  • Be able to read and communicate in English.
  • Able to provide their own consent.
  • Access to a computer with videoconferencing ability for initial consent and telescreen.

Exclusion criteria

  • Patients with unstable medical conditions that might make TMS unsafe. This includes current poorly controlled seizures.
  • Ferromagnetic metal in the head.
  • Pregnant.
  • Currently active substance abuse except tobacco.

Treatment and study plan

Left prefrontal Transcranial Magnetic Stimulation (TMS)

Device

FDA cleared TMS

FDA cleared TMS for treating depression

Device

This is FDA approved TMS

Primary outcomes

  1. Percent of depression responders

    Time frame: From baseline to 1 week immediately after treatment week

    Number of patients with >50% improvement in Phq-9 scores before and then after 5 days of treatment

  2. Improvement in Depression Symptoms

    Time frame: From baseline to 1 week immediately after treatment week

    Change in Phq-9 ratings from baseline to end of treatment

Study contacts

Contact information is provided by the study sponsor or research team.

Alexandra Herron, BA

CONTACT

[email protected]

Mark S George, MD

CONTACT

[email protected]

8438765142

Sponsors and collaborators

Lead sponsor

Medical University of South Carolina

Other

Registry information

Official study title

Portable Transcranial Magnetic Stimulation (TMS) in a Van for Treatment-Resistant Depression

Acronym: TMS

Important dates

Study start
2025
Primary completion
2027
Study completion
2028
First posted
Dec 27, 2024
Registry last updated
May 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.